SGI Omics Tools Firms See Opportunities in Burgeoning Synthetic Biology Industry Premium Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors. SGI-DNA Raises $25M in Series A Financing The synthetic biology and DNA data storage firm will use the funds to launch its BioXp 3200 automated gene synthesis and cloning platform. SGI-DNA Sees Deal With Belgium's VIB as Springboard to Building European Synthetic Genomics Business Premium The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers. Venter Institute, SGI Researchers Build Bacterial Genome Editing Platform With Yeast, CRISPR/Cas9 A new study in Scientific Reports describes how scientists were able to replace an entire gene in a bacterial genome to study its function. SGI-DNA Inks Distribution Deal With VWR The deal covers SGI-DNA's line of DNA construct assembly kits, which are based on its Gibson Assembly DNA cloning approach, in North America and Europe. Jun 7, 2013 Australia's TRI Taps SGI's Hardware to Support Biomedical Research Premium Mar 9, 2012 Japanese Genetics Institute Taps SGI Supercomputer for NGS Analysis Premium Nov 4, 2011 Kyoto University Taps SGI Infrastructure for GenomeNet Database, Bioinformatics Server Premium Dec 24, 2010 GenomeQuest, SGI Deploy Genome Analysis Platform for Ag Biotech Research at Biogemma Premium Dec 22, 2010 Biogemma, GenomeQuest, and SGI Team on Agriculture Genomics Jul 9, 2010 BioInform's Licensing Roundup: June's Software and IT Deals Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.